Cargando…

Characterisation of tumour blood flow using a 'tissue-isolated' preparation.

Tumour blood flow was characterised in a 'tissue-isolated' rat tumour model, in which the vascular supply is derived from a single artery and vein. Tumours were perfused in situ and blood flow was calculated from simultaneous measurement of (1) venous outflow from the tumour and (2) uptake...

Descripción completa

Detalles Bibliográficos
Autores principales: Tozer, G. M., Shaffi, K. M., Prise, V. E., Cunningham, V. J.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1994
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033701/
https://www.ncbi.nlm.nih.gov/pubmed/7981052
_version_ 1782136895030951936
author Tozer, G. M.
Shaffi, K. M.
Prise, V. E.
Cunningham, V. J.
author_facet Tozer, G. M.
Shaffi, K. M.
Prise, V. E.
Cunningham, V. J.
author_sort Tozer, G. M.
collection PubMed
description Tumour blood flow was characterised in a 'tissue-isolated' rat tumour model, in which the vascular supply is derived from a single artery and vein. Tumours were perfused in situ and blood flow was calculated from simultaneous measurement of (1) venous outflow from the tumour and (2) uptake into the tumour of radiolabelled iodo-antipyrine (IAP). Comparison of results from the two measurements enabled assessment of the amount of blood 'shunted' through the tumours with minimal exchange between blood and tissue. Kinetics of IAP uptake were also used to determine the apparent volume of distribution (VDapp) for the tracer and the equilibrium tissue-blood partition coefficient (lambda). lambda was also measured by in vitro techniques and checks were made for binding and metabolism of IAP using high-pressure liquid chromatography. VDapp and lambda were used to calculate the perfused fraction (alpha) of the tumours. Tumour blood flow, as measured by IAP (TBFIAP), was 94.8 +/- 4.4% of the blood flow as measured by venous outflow, indicating only a small amount of non-exchanging flow. This level of shunting is lower than some previous estimates in which the percentage tumour entrapment of microspheres was used. The unperfused fraction ranged from 0 to 20% of the tumour volume in the majority of tumours. This could be due to tumour necrosis and/or acutely ischaemic tumour regions. For practical purposes, measurement of the total venous outflow of tumours is a reasonable measure of exchangeable tumour blood flow in this system and allows for on-line measurements. Tracer methods can be used to obtain additional information on the distribution of blood flow within tumours.
format Text
id pubmed-2033701
institution National Center for Biotechnology Information
language English
publishDate 1994
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-20337012009-09-10 Characterisation of tumour blood flow using a 'tissue-isolated' preparation. Tozer, G. M. Shaffi, K. M. Prise, V. E. Cunningham, V. J. Br J Cancer Research Article Tumour blood flow was characterised in a 'tissue-isolated' rat tumour model, in which the vascular supply is derived from a single artery and vein. Tumours were perfused in situ and blood flow was calculated from simultaneous measurement of (1) venous outflow from the tumour and (2) uptake into the tumour of radiolabelled iodo-antipyrine (IAP). Comparison of results from the two measurements enabled assessment of the amount of blood 'shunted' through the tumours with minimal exchange between blood and tissue. Kinetics of IAP uptake were also used to determine the apparent volume of distribution (VDapp) for the tracer and the equilibrium tissue-blood partition coefficient (lambda). lambda was also measured by in vitro techniques and checks were made for binding and metabolism of IAP using high-pressure liquid chromatography. VDapp and lambda were used to calculate the perfused fraction (alpha) of the tumours. Tumour blood flow, as measured by IAP (TBFIAP), was 94.8 +/- 4.4% of the blood flow as measured by venous outflow, indicating only a small amount of non-exchanging flow. This level of shunting is lower than some previous estimates in which the percentage tumour entrapment of microspheres was used. The unperfused fraction ranged from 0 to 20% of the tumour volume in the majority of tumours. This could be due to tumour necrosis and/or acutely ischaemic tumour regions. For practical purposes, measurement of the total venous outflow of tumours is a reasonable measure of exchangeable tumour blood flow in this system and allows for on-line measurements. Tracer methods can be used to obtain additional information on the distribution of blood flow within tumours. Nature Publishing Group 1994-12 /pmc/articles/PMC2033701/ /pubmed/7981052 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Research Article
Tozer, G. M.
Shaffi, K. M.
Prise, V. E.
Cunningham, V. J.
Characterisation of tumour blood flow using a 'tissue-isolated' preparation.
title Characterisation of tumour blood flow using a 'tissue-isolated' preparation.
title_full Characterisation of tumour blood flow using a 'tissue-isolated' preparation.
title_fullStr Characterisation of tumour blood flow using a 'tissue-isolated' preparation.
title_full_unstemmed Characterisation of tumour blood flow using a 'tissue-isolated' preparation.
title_short Characterisation of tumour blood flow using a 'tissue-isolated' preparation.
title_sort characterisation of tumour blood flow using a 'tissue-isolated' preparation.
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033701/
https://www.ncbi.nlm.nih.gov/pubmed/7981052
work_keys_str_mv AT tozergm characterisationoftumourbloodflowusingatissueisolatedpreparation
AT shaffikm characterisationoftumourbloodflowusingatissueisolatedpreparation
AT priseve characterisationoftumourbloodflowusingatissueisolatedpreparation
AT cunninghamvj characterisationoftumourbloodflowusingatissueisolatedpreparation